Relitch 0.05%+0.1%+2.5% is a Product of the Generic Betamethasone + Phenylephrine + Lignocaine

Relitch 0.05%+0.1%+2.5% belongs to the generic category of Betamethasone + Phenylephrine + Lignocaine. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Relitch 0.05%+0.1%+2.5%. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Betamethasone + Phenylephrine + Lignocaine and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Description of Relitch 0.05%+0.1%+2.5%

Relitch 0.05%+0.1%+2.5% may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Relitch 0.05%+0.1%+2.5% is provided below to help users gain a clear understanding of this medicine.

What Is Relitch 0.05%+0.1%+2.5% Indications and Uses?

This preparation rectal ointment is indicated for relief of the symptoms of-

Itching,
Irritation,
Discomfort or pain associated with local non-infective anal or peri-anal conditions such as external hemorrhoids.

Pharmacology (Source, Chemical and Physical Composition) Of Relitch 0.05%+0.1%+2.5%

Betamethasone is a corticosteroid with mainly glucocorticoid activity. It induces phospholipase A2 inhibitory lipase (lipocortins) and sequentially inhibits the release of arachidonic acid, thereby depressing the formation, release, and activity of prostaglandins, leukotrienes, and other inflammatory mediators.Phenylephrine is a sympathomimetic with mainly direct effects on alpha-adrenergic receptors and weak beta-adrenergic activity. It causes vasoconstriction of the arterioles of the nasal mucosa and conjunctiva; activates the dilator muscle of the pupil to cause contraction; produces vasoconstriction of arterioles in the body and produces systemic arterial vasoconstriction.Lidocaine alters signal conduction in neurons by blocking the fast voltage-gated Na+ channels in the neuronal cell membrane responsible for signal propagation. With sufficient blockage, the membrane of the postsynaptic neuron will not depolarize and will thus fail to transmit an action potential.

Dosage And Administration of Relitch 0.05%+0.1%+2.5%

A course of treatment should be limited to 7 days. Apply a small amount of ointment two or three times a day initially, using the applicator if internal administration is required. When inflammation is subsiding, once-daily application is sufficient in most cases. Or as directed by the physician.

Side Effects of Relitch 0.05%+0.1%+2.5%

Signs of hypersensitivity may appear. Prolonged and intensive treatment with highly active corticosteroid preparations may cause local atrophic changes in the skin.

Use During Pregnancy and Lactation

There is inadequate evidence of safety in human pregnancy.

Precautions And Warnings for Relitch 0.05%+0.1%+2.5%

Long-term continuous therapy should be avoided where possible, particularly in infants and children, as adrenal suppression can occur.

Therapeutic Class

4-Quinolone preparations, Phlebotonic & Vascular protecting preparation

Storage Conditions of It

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Relitch 0.05%+0.1%+2.5% is a Product of the Generic Betamethasone + Phenylephrine + Lignocaine

Relitch 0.05%+0.1%+2.5%

Drug International Ltd. · Rectal Ointment

Betamethasone + Phenylephrine + Lignocaine